1973Hormone and Metabolic ResearchRequires access

Glucagon Radioimmunoassay Using Antiserum 30K: Interference by Plasma

Gordon C. Weir, R. Jay Turner, Donald Martin

Open publisher page 86 citations

Abstract

Studies of a glucagon radioimmunoassay using antiserum 30K suggest that when plasma samples from different individuals are assayed against a single standard curve, an inappropriately wide range of values for fasting human pancreatic glucagon levels is obtained. Evidence is presented that plasma from different subjects contains non-specific factors which interfere with the assay. These factors depress the binding of labeled glucagon but appear to be neither pancreatic glucagon nor an enteric factor with glucagon-like immunoreactivity. A correction can be made for these interference factors in a given patient because the factors can be quantitated following adsorption of glucagon with charcoal. Fasting immunoreactive glucagon (IRG) levels were determined on the plasma from 13 normal subjects. When all samples were measured against a standard curve using no correction factor the range was 45-295 pg/ml (mean ± standard deviation 131 ± 73.8). Using a correction factor the measured fasting glucagon values were 25-60 pg/ml (mean ± S.D. 43 ± 12.3). Fasting glucagon levels as conventionally determined using antiserum 30K are probably inaccurate, and the use of a correction factor is advisable.

About this research paper

What this paper is about

Studies of a glucagon radioimmunoassay using antiserum 30K suggest that when plasma samples from different individuals are assayed against a single standard curve, an inappropriately wide range of values for fasting human pancreatic glucagon levels is obtained. Evidence is presented that plasma from different subjects contains non-specific factors which interfere with the assay. These factors depress the binding of labeled glucagon but appear to be neither pancreatic glucagon nor an enteric factor with glucagon-like immunoreactivity. A correction can be made for these interference factors in a given patient because the factors can be quantitated following adsorption of glucagon with charcoal. Fasting immunoreactive glucagon (IRG) levels were determined on the plasma from 13 normal subjects. When all samples were measured against a standard curve using no correction factor the range was 45-295 pg/ml (mean ± standard deviation 131 ± 73.8). Using a correction factor the measured fasting glucagon values were 25-60 pg/ml (mean ± S.D. 43 ± 12.3). Fasting glucagon levels as conventionally determined using antiserum 30K are probably inaccurate, and the use of a correction factor is advisable.

Why it matters

OpenAlex reports 86 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Studies of a glucagon radioimmunoassay using antiserum 30K suggest that when plasma samples from different individuals are assayed against a single standard curve, an inappropriately wide range of values for fasting human pancreatic glucagon levels is obtained. Evidence is presented that plasma from different subjects contains non-specific factors which interfere with the assay. These factors depress the binding of labeled glucagon but appear to be neither pancreatic glucagon nor an enteric factor with glucagon-like immunoreactivity. A correction can be made for these interference factors in a given patient because the factors can be quantitated following adsorption of glucagon with charcoal. Fasting immunoreactive glucagon (IRG) levels were determined on the plasma from 13 normal subjects. When all samples were measured against a standard curve using no correction factor the range was 45-295 pg/ml (mean ± standard deviation 131 ± 73.8). Using a correction factor the measured fasting glucagon values were 25-60 pg/ml (mean ± S.D. 43 ± 12.3). Fasting glucagon levels as conventionally determined using antiserum 30K are probably inaccurate, and the use of a correction factor is advisable.

Key concepts: Glucagon, Radioimmunoassay, Internal medicine, Antiserum, Endocrinology, Chemistry, Medicine, Antibody

Related papers

Back to paper searchBrowse research topicsOriginal source
Glucagon Radioimmunoassay Using Antiserum 30K: Interference by Plasma — Research Paper | ScholarLens